SEC Info - Nika Pharmaceuticals, Inc. - ‘8-K’ for 9/18/23

SEC Info℠

Home

Help

Please Sign In

Nika Pharmaceuticals, Inc. – ‘8-K’ for 9/18/23 – ‘EX-16.1’

On: Monday, 9/18/23, at 4:19pm ET · For: 9/18/23 · Accession #: 1826466-23-33 · File #: 0-56234

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/18/23  Nika Pharmaceuticals, Inc.        8-K:1,2,3,5 9/18/23   19:3.9M                                   EDGARhub LLC/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report -- form8k                            HTML     79K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML     10K 
                Liquidation or Succession -- exhibit2-1                          
 3: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     18K 
                -- exhibit3-2                                                    
 4: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     17K 
                -- exhibit3-3                                                    
 5: EX-10.1     Material Contract -- exhibit10-1                    HTML      8K 
 6: EX-10.2     Material Contract -- exhibit10-2                    HTML      8K 
 7: EX-10.3     Material Contract -- exhibit10-3                    HTML      7K 
 8: EX-10.4     Material Contract -- exhibit10-4                    HTML      7K 
 9: EX-10.5     Material Contract -- exhibit10-5                    HTML      8K 
10: EX-16.1     Letter re: a Change in Accountant -- exhibit16-1    HTML      8K 
14: R1          Cover                                               HTML     44K 
17: XML         IDEA XML File -- Filing Summary                      XML     13K 
15: XML         XBRL Instance -- form8k_htm                          XML     16K 
16: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
12: EX-101.LAB  XBRL Labels -- nika-20230914_lab                     XML     98K 
13: EX-101.PRE  XBRL Presentations -- nika-20230914_pre              XML     65K 
11: EX-101.SCH  XBRL Schema -- nika-20230914                         XSD     14K 
18: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    36K 
19: ZIP         XBRL Zipped Folder -- 0001826466-23-000033-xbrl      Zip     40K

‘EX-16.1’ — Letter re: a Change in Accountant — exhibit16-1

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Nika Pharmaceuticals, Inc.: Exhibit 16.1 - Filed by EDGARhub LLC

Exhibit 16.1

September 13, 2023

Securities and Exchange Commission (the “Commission”)
100 F Street, NE
Washington, DC 20549

Dear Ladies and Gentleman:

We are the former independent registered public accounting firm for Nika Pharmaceuticals, Inc.(the “Company”). We have read the statements made by the Company, which were provided to us and which we understand will be filed with the Commission pursuant to Item 4.01 Changes in Registrant’s Certifying Accountant of its current report on Form 8-K (the “Current Report”) and are in agreement with the disclosure in the Current Report, insofar as it pertains to our firm.

We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.

Sincerely,

/s/ Pinnacle Accountancy Group of Utah

PINNACLE ACCOUNTANCY GROUP OF UTAH
Farmington, UT

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	9/18/23	None on these Dates
	9/13/23
		List all Filings

↑Top

Filing Submission 0001826466-23-000033 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)